New approaches in childhood asthma treatment

被引：6
作者：
Castagnoli, Riccardo [1 ,2 ]
Brambilla, Ilaria [1 ,2 ]
Giovannini, Mattia [3 ,4 ,5 ]
Marseglia, Gian Luigi [1 ,2 ]
Licari, Amelia [1 ,2 ]
机构：
[1] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pediat Unit, Pavia, Italy
[2] Fdn IRCCS Policlin San Matteo, Pediat Clin, Pavia, Italy
[3] Meyer Childrens Hosp IRCCS, Allergy Unit, Florence, Italy
[4] Univ Florence, Dept Hlth Sci, Florence, Italy
[5] Univ Florence, Meyer Childrens Hosp IRCCS, Dept Hlth Sci, Allergy Unit, Viale Pieraccini 24, I-50139 Florence, Italy
来源：
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 23卷 / 04期
关键词：
asthma; biologics; children; therapy; DOUBLE-BLIND; CHILDREN; OMALIZUMAB; THERAPY; TEZEPELUMAB; BENRALIZUMAB; MALIGNANCY; RECEPTOR; SAFETY; ADULTS;
D O I：
10.1097/ACI.0000000000000922
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Purpose of reviewThis review aims to summarize the most recent advances in asthma management, focusing on novel approaches to pediatric asthma.Recent findingsIn recent years, the therapeutic tools for pediatric asthma have expanded significantly for both the nonsevere and severe forms. The use of anti-inflammatory treatment, even for the mildest cases, and the withdrawal of symptomatic bronchodilation as monotherapy have been included in the most recent guidelines. Also, different biological therapies have revolutionized the therapeutical approach for severe uncontrolled asthma in children and adolescents.With the expanding landscape of novel therapeutic approaches for pediatric asthma, further evidence is needed to help clinicians choose the best option for patients, particularly those with severe asthma. The identification of novel predictive biomarkers may also help pediatricians in selecting children and adolescents for innovative therapies.
引用
收藏
页码：319 / 326
页数：8
相关论文
共 68 条
  • [1] Challenges in uncontrolled asthma in pediatrics: important considerations for the clinician
    Andrenacci, Beatrice
    Ferrante, Giuliana
    Roberto, Giulia
    Piacentini, Giorgio
    La Grutta, Stefania
    Marseglia, Gian Luigi
    Licari, Amelia
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (08) : 807 - 821
  • [2] [Anonymous], 2023, 2022 GINA REP GLOB S
  • [3] asthma, WHY ASTHM STILL KILL
  • [4] Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth
    Axelsson, Inge
    Naumburg, Estelle
    Prietsch, Silvio O. M.
    Zhang, Linjie
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (06):
  • [5] Biologics in the treatment of asthma in children and adolescents
    Bacharier, Leonard B.
    Jackson, Daniel J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (03) : 581 - 589
  • [6] Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Constance H.
    Fiocchi, Alessandro G.
    Gagnon, Remi
    de Mir, Ines
    Jain, Neal
    Sher, Lawrence D.
    Mao, X.
    Liu, D.
    Zhang, Yi
    Khan, Asif H.
    Kapoor, Upender
    Khokhar, Faisal A.
    Rowe, Paul J.
    Deniz, Yamo
    Ruddy, Marcella
    Laws, Elizabeth
    Patel, Naimish
    Weinreich, David M.
    Yancopoulos, George D.
    Amin, Nikhil
    Mannent, Leda P.
    Lederer, David J.
    Hardin, Megan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24) : 2230 - 2240
  • [7] Budesonide/formoterol maintenance plus reliever therapy -: A new strategy in pediatric asthma
    Bisgaard, Hans
    Le Roux, Pascal
    Bjamer, Ditlef
    Dymek, Andrzej
    Vermeulen, Jan H.
    Hultquist, Christer
    [J]. CHEST, 2006, 130 (06) : 1733 - 1743
  • [8] Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
    Bleecker, Eugene R.
    FitzGerald, J. Mark
    Chanez, Pascal
    Papi, Alberto
    Weinstein, Steven F.
    Barker, Peter
    Sproule, Stephanie
    Gilmartin, Geoffrey
    Aurivillius, Magnus
    Werkstrom, Viktoria
    Goldman, Mitchell
    [J]. LANCET, 2016, 388 (10056) : 2115 - 2127
  • [9] Biologic Therapies for Severe Asthma
    Brusselle, Guy G.
    Koppelman, Gerard H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (02) : 157 - 171
  • [10] Omalizumab and the risk of malignancy: Results from a pooled analysis
    Busse, William
    Buhl, Roland
    Vidaurre, Carlos Fernandez
    Blogg, Martin
    Zhu, Jin
    Eisner, Mark D.
    Canvin, Janice
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (04) : 983 - U482
1234567